Javascript must be enabled to continue!
Antiproliferative Effects of Artabotrys odoratissimus Fruit Extract and its Bioactive Fraction through Upregulation of p53/γH2AX Signals and G2/M Phase Arrest in MIA PaCa-2 Cells
View through CrossRef
Background:
Artabotrys odoratissimus (Annonaceae) is a medicinal and ornamental plant widely cultivated
in Southeast Asia for its famous ylang ylang essential oil. The fruits of this plant are used for health benefits, but very
little is studied about the bioactive principles, their role in regulating oxidative stress and tumour progression.
Objective:
The study aimed to evaluate the antiproliferative effects of fruit extract of Artabotrys odoratissimus and its
bioactive fraction using cell-based assays.
Methods:
The free radical scavenging and antiproliferative effects of Artabotrys odoratissimus fruit ethyl acetate
(FEA) extract and its bioactive fraction were evaluated using cell viability assays, colony formation assay, double
staining assay, reactive oxygen species (ROS) assay, comet assay, cell cycle analysis, and western blotting.
Results:
The extract showed phenolic content of 149.8±0.11μg/mg Gallic acid equivalents and flavonoid content of
214.47±4.18 μg/mg Quercetin. FEA showed an IC50 value of 76.35 μg/ml in the ABTS assay and an IC50 value of
134.3±7.8 μg/ml on MIA PaCa-2 cells. The cells treated with 125 μg/ml and 250 μg/ml FEA showed increased apoptotic
cells in Double staining assay, DNA damage during comet assay, enhanced ROS, and cell cycle arrest at G2M
phase at 125 μg/ml and 250 μg/ml. The active fraction AF5 showed an IC50 value of 67±1.26 μg/ml on MIA PaCa-2
cells during MTT assay, displayed potential antiproliferative effects, and showed a marked increase in the expression
of γH2AX and p53.
Conclusion:
These results prove that the fruit extract and the bioactive fraction demonstrate oxidative stress-mediated
DNA damage, leading to apoptosis in the MIA PaCa-2 cell line.
Title: Antiproliferative Effects of Artabotrys odoratissimus Fruit Extract and its Bioactive
Fraction through Upregulation of p53/γH2AX Signals and G2/M Phase Arrest in
MIA PaCa-2 Cells
Description:
Background:
Artabotrys odoratissimus (Annonaceae) is a medicinal and ornamental plant widely cultivated
in Southeast Asia for its famous ylang ylang essential oil.
The fruits of this plant are used for health benefits, but very
little is studied about the bioactive principles, their role in regulating oxidative stress and tumour progression.
Objective:
The study aimed to evaluate the antiproliferative effects of fruit extract of Artabotrys odoratissimus and its
bioactive fraction using cell-based assays.
Methods:
The free radical scavenging and antiproliferative effects of Artabotrys odoratissimus fruit ethyl acetate
(FEA) extract and its bioactive fraction were evaluated using cell viability assays, colony formation assay, double
staining assay, reactive oxygen species (ROS) assay, comet assay, cell cycle analysis, and western blotting.
Results:
The extract showed phenolic content of 149.
8±0.
11μg/mg Gallic acid equivalents and flavonoid content of
214.
47±4.
18 μg/mg Quercetin.
FEA showed an IC50 value of 76.
35 μg/ml in the ABTS assay and an IC50 value of
134.
3±7.
8 μg/ml on MIA PaCa-2 cells.
The cells treated with 125 μg/ml and 250 μg/ml FEA showed increased apoptotic
cells in Double staining assay, DNA damage during comet assay, enhanced ROS, and cell cycle arrest at G2M
phase at 125 μg/ml and 250 μg/ml.
The active fraction AF5 showed an IC50 value of 67±1.
26 μg/ml on MIA PaCa-2
cells during MTT assay, displayed potential antiproliferative effects, and showed a marked increase in the expression
of γH2AX and p53.
Conclusion:
These results prove that the fruit extract and the bioactive fraction demonstrate oxidative stress-mediated
DNA damage, leading to apoptosis in the MIA PaCa-2 cell line.
Related Results
Abstract 1176: Bypassing the dominant-negative effect of mutant p53 in cancer cells
Abstract 1176: Bypassing the dominant-negative effect of mutant p53 in cancer cells
Abstract
The tumor suppressor p53 is mutated in more than 50% of all cancers. The transcriptional activity of p53 depends on localization to the nucleus and formatio...
High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia
High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia
Abstract
Abstract 1490
Background:
The tumor suppressor p53 is frequently mutated in human cancer, including acut...
Abstract 1706: Investigating the interaction between ETS family members and mutant p53
Abstract 1706: Investigating the interaction between ETS family members and mutant p53
Abstract
Cancer cases are on the rise globally requiring a deeper understanding of the disease and identification of novel therapeutic targets. Mutations in genes of...
Abstract 599: Id4 acts as a tumor suppressor by inducing apoptosis and senescence in p53-dependent manner
Abstract 599: Id4 acts as a tumor suppressor by inducing apoptosis and senescence in p53-dependent manner
Abstract
The physiological mechanisms that can restore biological activity of mutant p53 is an area of high interest given that mutant p53 expression is observed in ...
Abstract 829: p53 dimers elicit tumor suppressive activities through an altered metabolic program
Abstract 829: p53 dimers elicit tumor suppressive activities through an altered metabolic program
Abstract
p53 is the most frequently mutated gene in human cancer. As a tetrameric transcription factor, mutation of the p53 Tetramerization Domain (TD) is a mechanis...
Abstract 3500: Mitochondrially targeted p53 domains as a stand alone or adjunct to paclitaxel for the treatment of ovarian cancer
Abstract 3500: Mitochondrially targeted p53 domains as a stand alone or adjunct to paclitaxel for the treatment of ovarian cancer
Abstract
Although the main function of p53 is a nuclear transcription factor that has important roles in cell cycle arrest, DNA repair, and apoptosis, p53 can direct...
Abstract 422: Novel approach to destabilization of oncogenic mutant p53 and therapeutic implications
Abstract 422: Novel approach to destabilization of oncogenic mutant p53 and therapeutic implications
Abstract
Introduction: Mutant p53 drives several hallmarks of cancer through a gain-of-function oncogenic program. The oncogenicity of mutant p53 includes sustained ...
Jun Dimerization Protein 2 (JDP2) Increases p53 Transactivation by Decreasing MDM2
Jun Dimerization Protein 2 (JDP2) Increases p53 Transactivation by Decreasing MDM2
The AP-1 protein complex primarily consists of several proteins from the c-Fos, c-Jun, activating transcription factor (ATF), and Jun dimerization protein (JDP) families. JDP2 has ...

